PDL BioPharma, Inc. (PDLI) Completes Structured Financing and Royalty Transaction With Avinger, Inc.
4/23/2013 9:06:04 AM
More...
|
PDL BioPharma, Inc. (PDLI) Will Provide Avinger, Inc. With Up to $40 Million Financing
4/22/2013 7:30:38 AM
More...
|
Avinger, Inc. Receives FDA Clearance for Ocelot | PIXL
12/18/2012 9:29:59 AM
More...
|
Avinger, Inc.'s Ocelot System is FDA Cleared
11/8/2012 10:37:44 AM
More...
|
Avinger, Inc. Raises $33 Million in Series D Financing
7/10/2012 9:12:37 AM
More...
|
Avinger, Inc. Completes Enrollment of PAD-Focused CONNECT II Global Clinical Trial
6/12/2012 10:37:58 AM
More...
|
Participates in Avinger, Inc.'s CONNECT II Global Clinical Trial
5/9/2012 12:02:51 PM
More...
|
Avinger, Inc. Enrolls First U.S. PAD Patient in CONNECT II Global Clinical Trial
3/7/2012 7:55:57 AM
More...
|
Avinger, Inc. Enrolls First European PAD Patient in CONNECT II Global Clinical Trial
2/24/2012 6:30:30 AM
More...
|
Avinger, Inc. to Perform Two Live Ocelot Cases at LINC Conference in Leipzig, Germany
1/25/2012 6:05:41 AM
More...
|
|